Thoracic duct lymph flow changes secondary to alterations in serum calcium levels: a proposed mechanism of action.
D000809:Angiotensins / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000097:blood*; D003472:Curare / Q000494:pharmacology; D004285:Dogs; D005260:Female; D008196:Lymph / Q000187:drug effects / Q000502:physiology*; D008297:Male; D010276:Parasympatholytics / Q000494:pharmacology; D013390:Succinylcholine / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology; D013897:Thoracic Duct / Q000502:physiology*
D000809:Angiotensins; D010276:Parasympatholytics; D013565:Sympatholytics; D013566:Sympathomimetics; D003472:Curare; D013390:Succinylcholine; D002118:Calcium